GMED — GLOBUS MEDICAL INC
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1237831 ·
Last close
$82.52
Market Cap
$9.35B
52W High
$97.39
52W Low
$74.50
ADV30
1,850,597
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 759,854,000 | 525,788,000 | 161,977,000 | 124,302,000 | 5,439,555,000 | 560,950,000 | 707,243,000 |
| Dec 2025 | 826,420,000 | 565,313,000 | 181,310,000 | 140,594,000 | 5,302,761,000 | 526,156,000 | 729,511,000 |
| Sep 2025 | 769,048,000 | 516,515,000 | 135,008,000 | 118,966,000 | 5,095,640,000 | 371,769,000 | 696,815,000 |
| Jun 2025 | 745,342,000 | 496,577,000 | 122,812,000 | 202,846,000 | 4,961,089,000 | 229,446,000 | 665,406,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$778,511,000
Investing CF
$-669,073,000
Financing CF
$-25,567,000
CapEx
$-177,937,000
Dividends Paid
—
Buybacks
$-110,000,000
EPS Diluted TTM
$4.30
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$1,512,259,000
Inventory
$772,602,000
Receivables
$735,439,000
ST Investments
$68,901,000
EBIT TTM
$601,107,000
Pretax Income TTM
$658,474,000
Interest Exp TTM
—
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,100,664,064
EBITDA
$945,059,008
Free Cash Flow
$341,059,616
Enterprise Value
$10,114,893,824
Total Cash
$629,851,008
Total Debt
$115,941,000
Shares Out
113,314,529
Trailing EPS
$4.28
Book Value
$34.88
ROE
13.3%
ROA
8.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,938,931,000 | 537,191,000 | 537,868,000 | 5,302,761,000 | 729,511,000 | — | 753,447,000 |
| Dec 2024 | 2,519,355,000 | 219,387,000 | 102,984,000 | 5,251,750,000 | 1,074,417,000 | — | 520,638,000 |
| Dec 2023 | 1,568,476,000 | 201,416,000 | 122,873,000 | 5,086,083,000 | 1,088,124,000 | — | 243,499,000 |
| Dec 2022 | 1,022,843,000 | 236,251,000 | 190,169,000 | 2,076,126,000 | 229,753,000 | — | 178,468,000 |
TTM Snapshot
Revenues TTM
$1,142,900,000
NetIncome TTM
$150,942,000
OpCashFlow TTM
$0
Assets (Latest)
$5,251,750,000
Forward EPS
$5.15
Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)
max pain strike: $80.00 · spot: $82.52 · call volume: 397 · put volume: 7
Expected Move to 2026-07-17:
±$7.20
(8.73%) —
implied range
$75.32 –
$89.72
· ATM straddle on $82.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MASI | MASIMO CORP | $9.42B | $179.95 | — |
| BAX | BAXTER INTERNATIONAL INC | $10.34B | $20.03 | — |
| PODD | INSULET CORP | $11.06B | $159.61 | — |
| GKOS | GLAUKOS Corp | $7.42B | $126.34 | — |
| PEN | Penumbra Inc | $12.63B | $321.06 | — |
News headlines (Yahoo Finance, 1h cache)
Here is Why Globus Medical (GMED) is One of the Most Profitable Growth Stocks to Buy
2026-06-09 23:22 · Yahoo
Should You Add Myriad Genetics Stock to Your Portfolio Right Now?
2026-06-09 14:01 · Yahoo
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
2026-06-09 14:01 · Yahoo
Is This the Right Time to Retain Resmed Stock in Your Portfolio?
2026-06-09 12:55 · Yahoo
2 Reasons to Watch GMED and 1 to Stay Cautious
2026-06-08 18:13 · Yahoo
DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes
2026-06-08 17:29 · Yahoo
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now
2026-06-08 15:52 · Yahoo
Here's Why You Should Retain NVST Stock in Your Portfolio for Now
2026-06-08 15:49 · Yahoo
NTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC
2026-06-08 15:48 · Yahoo
Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect?
2026-06-08 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.